Upgrade to SI Premium - Free Trial

VSQTF (VSQTF)

0.30 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Insu Therapeutics gets U.S. patent allowance for buccal drug delivery October 8, 2026 7:30 AM - StreetInsider Insu Therapeutics receives U.S. patent allowance for buccal insulin delivery October 8, 2026 7:30 AM - StreetInsider Victory Square Announces U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Platform October 8, 2026 7:30 AM - PR NewsWire Hydreight Highlights U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Technology October 8, 2026 7:30 AM - PR NewsWire Victory Square Technologies Ranks No. 2 Among Publicly Traded Companies on The Globe and Mail's 2026 Canada's Top Growing Companies List October 6, 2026 8:01 AM - PR NewsWire Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A August 27, 2026 7:30 AM - PR NewsWire Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances July 29, 2026 8:01 AM - PR NewsWire Hydreight Provides Business Update on its Peptide Healthcare Platform Following Recent FDA Advisory Committee Recommendations July 29, 2026 7:00 AM - PR NewsWire Full Article List